Publication | Closed Access

EGFR blockade with ZD1839 (“Iressa”) potentiates the antitumor effects of single and multiple fractions of ionizing radiation in human A431 squamous cell carcinoma

Radiation MedicineOncologyRadiation TherapyMedicineCancer Cell BiologyAntitumor EffectsCell BiologyEgfr BlockadeCancer TreatmentMultiple FractionsPharmacologyRadiation Oncology